¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"anti"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • antigen analysis
    Ç׿øºÐ¼®
  • antigen binding capacity
    Ç׿ø°áÇÕ´É
  • antigen binding fragment
    Ç׿ø°áÇÕºÎÀ§
  • antigen binding receptor
    Ç׿ø°áÇÕ¼ö¿ëü
  • antigen capture assay
    Ç׿øÆ÷È¹ÃøÁ¤
  • antigen competition
    Ç׿ø°æÀï
  • antigen diffusion constant
    Ç׿øÈ®»ê»ó¼ö
  • antigen excess
    Ç׿ø°úÀ×
  • antigen excess zone
    Ç׿ø°úÀ×±¸¿ª
  • antigen mimicry
    Ç׿øÀ¯»ç¼º
  • antigen modification
    Ç׿øº¯È­, Ç׿ø¼ö½Ä
  • antigen presentation
    Ç׿øÁ¦½Ã
  • antigen receptor
    Ç׿ø¼ö¿ëü
  • antigen recognition
    Ç׿øÀνÄ
  • antigen-antibody complex
    Ç׿øÇ×üº¹ÇÕü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • antigen receptor
    Ç׿ø¼ö¿ëü
  • antigen recognition
    Ç׿øÀÎÁö
  • antigen-antibody complex
    Ç׿øÇ×üº¹ÇÕü
  • antigen-antibody interaction
    Ç׿øÇ×ü¹ÝÀÀ
  • antigen-antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
  • antigen-binding site
    Ç׿ø°áÇÕºÎÀ§
  • antigen-combining site
    Ç׿ø°áÇÕºÎÀ§
  • antigen-presenting cell
    Ç׿øÀü´Þ¼¼Æ÷
  • antigen-reactive cell
    Ç׿ø¹ÝÀÀ¼¼Æ÷
  • antigen-recognition site
    Ç׿øÀÎÁöºÎÀ§
  • antigen-recognizing cell
    Ç׿øÀÎÁö¼¼Æ÷
  • antigenemia
    Ç׿øÇ÷Áõ
  • antigenic deletion
    Ç׿ø°á¼Õ
  • antigenic determinant
    Ç׿ø°áÁ¤±â
  • antigenic diversion
    Ç׿øÀüȯ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • antibody to HBs ag
    B Çü °£¿°Ç¥¸éÇ׿ø¿¡´ëÇÑ Ç×ü
  • antibody to HD ag
    HD Ç׿ø¿¡´ëÇÑ Ç×ü
  • antibody to histidyl tRNa synthetase
    È÷½ºÆ¼µô tRNa ÇÕ¼ºÈ¿¼Ò¿¡ ´ëÇÑ Ç×ü
  • antibody to thyroglobulin
    Ƽ·Î±Û·ÎºÒ¸°<°©»ó¼±±Û·ÎºÒ¸°>¿¡ ´ëÇÑ Ç×ü
  • antibody to thyrotropin
    °©»ó¼±ÀÚ±ØÈ£¸£¸ó¿¡ ´ëÇÑ Ç×ü
  • antibody transfer
    Ç×üÀÌÀÔ(¡­ì¹ìý).
  • antibody unit
    Ç×ü´ÜÀ§(ù÷ô÷Ó¤êÈ).
  • antibody unit
    Ç×ü´ÜÀ§(ù÷ô÷Ó¤êÈ).
  • antibody unit
    Ç×ü´ÜÀ§(ù÷ô÷Ó¤êÈ).
  • antibody valence
    Ç×ü°áÇÕ°¡(¡­Ì¿ùêʤ).
  • antibody, blocking
    Â÷´ÜÇ×ü
  • antibody, cold
    ÇÑ·©Ç×ü
  • antibody, colostral
    ÃÊÀ¯Ç×ü
  • antibody, complement binding
    º¸Ã¼°áÇÕÇ×ü
  • antibody, complement fixing
    º¸Ã¼°áÇÕÇ×ü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • antibody to HBs ag
    B Çü °£¿°Ç¥¸éÇ׿ø¿¡´ëÇÑ Ç×ü
  • antibody to HD ag
    HD Ç׿ø¿¡´ëÇÑ Ç×ü
  • antibody to histidyl tRNa synthetase
    È÷½ºÆ¼µô tRNa ÇÕ¼ºÈ¿¼Ò¿¡ ´ëÇÑ Ç×ü
  • antibody to thyroglobulin
    Ƽ·Î±Û·ÎºÒ¸°<°©»ó¼±±Û·ÎºÒ¸°>¿¡ ´ëÇÑ Ç×ü
  • antibody to thyrotropin
    °©»ó¼±ÀÚ±ØÈ£¸£¸ó¿¡ ´ëÇÑ Ç×ü
  • antibody transfer
    Ç×üÀÌÀÔ(¡­ì¹ìý).
  • antibody unit
    Ç×ü´ÜÀ§(ù÷ô÷Ó¤êÈ).
  • antibody unit
    Ç×ü´ÜÀ§(ù÷ô÷Ó¤êÈ).
  • antibody unit
    Ç×ü´ÜÀ§(ù÷ô÷Ó¤êÈ).
  • antibody valence
    Ç×ü°áÇÕ°¡(¡­Ì¿ùêʤ).
  • antibody, blocking
    Â÷´ÜÇ×ü
  • antibody, cold
    ÇÑ·©Ç×ü
  • antibody, colostral
    ÃÊÀ¯Ç×ü
  • antibody, complement binding
    º¸Ã¼°áÇÕÇ×ü
  • antibody, complement fixing
    º¸Ã¼°áÇÕÇ×ü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • antisigma factor
    Ç×(ù÷)½Ã±×¸¶ ÀÎÀÚ(ì×í­)
  • antispecificity factor
    Çׯ¯À̼º ÀÎÀÚ(ù÷÷åì¶àõì×í­)
  • antisterility factor
    Ç׺ÒÀÓ ÀÎÀÚ(ù÷ÝÕìõì×í­)
  • antitermination
    Ç×Á¾·á(ù÷ðûÖõ)
  • antitermination factor
    Ç×Á¾·á ÀÎÀÚ(ù÷ðûÖõì×í­)
  • antithrombin
    Ç×(ù÷)Æ®·Òºó
  • antithyroid agent
    Ç×°©»ó¼±Á¦(ù÷Ë£ßÒàÍð¥)
  • antithyroid compound
    Ç×°©»ó¼± È­ÇÕ¹°(ù÷Ë£ßÒàÍûùùêÚª)
  • antitoxin
    Ç×µ¶¼Ò(Ô¸áÈ)
  • antitranscription terminator
    Ç×Àü»ç Á¾·áÀÚ(ù÷ï®ÞÐðûÖõí­)
  • antitrypsin
    Ç×(ù÷)Æ®¸³½Å
  • antitumor antibiotics
    Ç×Á¾¾ç Ç×»ýÁ¦(ù÷ðþåËù÷ßæð¥)
  • antitumor antimetabolite
    Ç×Á¾¾ç Ç×´ë»ç¹°(ù÷ðþåËù÷ÓÛÞóÚª)
  • antitumor enzyme
    Ç×Á¾¾ç È¿¼Ò(ù÷ðþåËý£áÈ)
  • antitumor protein
    Ç×Á¾¾ç ´Ü¹éÁú(ù÷ðþåËÓ±ÛÜòõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
ATA alimentary toxic aleukia; American Thyroid Association; aminotriazole; antithymic activity; antithyr...
AWRS anti-whole rabbit serum
BAL blood alcohol level; British anti-lewisite; bronchoalveolar lavage
BAS balloon atrial septostomy; benzyl anti-serotinin; beta-adrenergic stimulation; boric acid solution
C-ANCA cytoplasmic anti-neutrophilic cytoplasmic antibody
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
GBM Anti-glomerular basement membrane
GAD Anti-glutamic acid decarboxylase
GM-CSF Anti-granulocyte-macrophage colony-stimulating factor
HBV Anti-hepatitis B virus
HCV Anti-hepatitis C virus
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • Y42.2
    Antithyroid drugs
    Ç×°©»ó»ùÁ¦
  • T38.2
    Antithyroid drugs
    Ç×°©»ó»ù ¾à¹°
  • T48.3
    Antitussives
    ±âħ¾à
  • Y55.3
    Antitussives
    ±âħ¾à
  • Y52.8
    Antivaricose drugs, including sclerosing agents
    Ç×Á¤¸Æ·ù¾àÁ¦, °æÈ­Á¦ Æ÷ÇÔ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • antihemophilic factor
    Ç×Ç÷¿ìº´ ÀÎÀÚ
  • antihemorrhagic
    Ç×ÃâÇ÷¼ºÀÇ
    ÃâÇ÷À» ÀúÁöÇÏ´Â.
  • antihistamine
    Ç×È÷½ºÅ¸¹Î, Ç×È÷½ºÅ¸¹ÎÁ¦, Ç×È÷½ºÅ¸¹Î ¾à, Ç×È÷½ºÅ¸¹Î¼ºÀÇ
    1. È÷½ºÅ¸¹ÎÀÇ ÀÛ¿ë¿¡ ±æÇ×ÇÏ´Â ¾à¹°. Ç×È÷½ºÅ¸¹ÎÁ¦´Â µÎ Á¾·ù°¡ ÀÖ´Ù. ÁÖµÈ Çϳª´Â, ¾Ë·¯Áö¿¡ »ç¿ëµÇ´Â °ÍÀ¸·Î, H1 È÷½ºÅ¸¹Î ¸®¼ÁÅ͸¦ Â÷´ÜÇϰí, ´Ù¸¥ Çϳª´Â H2 ¸®¼ÁÅ͸¦ Â÷´ÜÇÑ´Ù. `Ç× È÷½ºÅ¸¹Î¼ºÀÇ'ÀÇ ¶æÀ¸·Îµµ »ç¿ëµÈ´Ù. 2. ¾Ë·¹¸£±â ÁúȯÀÇ ÇÑ ¿øÀÎÀÎ È÷½ºÅ¸¹ÎÀÇ ÀÛ¿ë¿¡ ±æÇ×ÇÏ´Â ¾àÁ¦. Ç×È÷½ºÅ¸¹Î ÀÛ¿ë ¿Ü¿¡ ±¹¼Ò¸¶Ã롤±³°¨½Å°æ Â÷´Ü¡¤ºÎ±³°¨½Å°æ Â÷´Ü¡¤ÁøÁ¤¡¤ÁøÅäÀÛ¿ëÀÌ ÀÖ´Ù. ÁÖ·Î ¾Ë·¹¸£±âÁõ¡¤±â°üÁö õ½Ä¡¤µÎµå·¯±â¡¤¾à¹°Áø¡¤Ç÷ûº´ ¿Ü¿¡, °¨±âÀÇ Ãʱ⳪ Â÷¸Ö¹Ì¿¡ »ç¿ëµÈ´Ù. ¶Ç ¿¬°íÁ¦·Î¼­ ¾Ë·¹¸£±â¼º ÇǺκ´¿¡µµ »ç¿ëµÈ´Ù. ³»º¹À» ÇÒ ¶§´Â Á¹À½ÀÌ ¿À°Å³ª ¼ÒÈ­ºÒ·®¡¤ÈïºÐ µîÀÇ ºÎÀÛ¿ëÀÌ ÀÖ´Ù. ¨ç µðÆæÈ÷µå¶ó¹Î : ³»º¹¿¡´Â ¹«¹ÌÀÇ Å¸´Ñ»ê¿°À» ¾´´Ù. ¨è ÇÁ·Î¸ÞŸµò : ¾ÆÅäÇǼº ÇǺο°¡¤°­È­¸¶Ãë¿¡µµ ¾²ÀδÙ. ¨é Æ®¸®Æä·¹³ª¹Î : À§ÀåÀå¾Ö¸¦ ÀÏÀ¸Å°´Â °æ¿ì°¡ ÀÖ´Ù. ¨ê Æä³ëƼ¾ÆÁø : ÁøÅëÀÛ¿ëÀÌ ÀÖ´Ù. ¨ë Ŭ·Î·ÎÆä´Ï¶ó¹Î : ºÎÀÛ¿ëÀÌ Àû´Ù. ¨ì ¾ÈŸÁ¹¸° : ÀڱؼºÀÌ ¾àÇϹǷΠ¾Ë·¹¸£±â¼º ¾È Áúȯ¿¡ ¾²ÀδÙ. ¨í ¹ÌÅ©¶óƾ : ¿À½É¡¤±¸Å䡤Â÷¸Ö¹Ì¡¤ÀÔµ¡¿¡ ¾²ÀδÙ. ¨î ÆÇÅ縱 : Ç׾Ƽ¼Æ¿Äݸ° ÀÛ¿ëÀÌ ÀÖ´Ù.
  • antihistaminic drug
    Ç×È÷½ºÅ¸¹Î ¾à
    È÷½ºÅ¸¹Î ÀÛ¿ë¿¡ ±æÇ×ÇÏ´Â ¾à¹°.
  • antihydropic
    Ç׺ÎÁ¾ÀÇ, Ç׺ÎÁ¾ ¾à, Ç׺ÎÁ¾ÀÇ, Ç×¼öÁ¾ÀÇ, Ç×¼öÁ¾ ¾à
    ºÎÁ¾À» °æ°¨½ÃŰ´Â. ºÎÁ¾ »ïÃâ¾×À» ¼Ò½Ç½ÃŰ´Â ¾à¹°.
  • antihyperglycemic
    Ç×°íÇ÷´çÁ¦, Ç×°íÇ÷´çÀÇ, Ç×°íÇ÷´ç¼ºÀÇ
  • antihypertensive
    Ç×°íÇ÷¾Ð, °íÇ÷¾Ð Ä¡·á ¾à, Ç×°íÇ÷¾ÐÀÇ, Ç×°íÇ÷¾Ð¼ºÀÇ, Ç×°íÇ÷¾ÐÁ¦
    ³ôÀº Ç÷¾ÐÀ» ³·Ãß´Â Á¦Á¦.
  • antihypotensive
    Ç×ÀúÇ÷¾Ð, Ç×ÀúÇ÷¾ÐÁ¦, Ç×ÀúÇ÷¾Ð ¾à, Ç×ÀúÇ÷¾ÐÀÇ, Ç×ÀúÇ÷¾Ð¼ºÀÇ
    Ç÷¾ÐÀ» »ó½Â½ÃŰ´Â ¾à¹°. Ç÷¾ÐÀ» »ó½Â½ÃŰ´Â.
  • antiinflammatory
    Ç׿°ÀÇ, Ç׿°ÁõÀÇ
  • antiinflammatory drug
    ¼Ò¿°Á¦
  • antiinsulin antibody
    Ç×Àν¶¸° Ç×ü
  • antileprotic
    Ç׳ªº´ ¾à, ³ªº´ Ä¡·á¾à, Ç׳ªÀÇ, Ç׳ª¼ºÀÇ
  • antiluetic
    Ç׸ŵ¶Á¦
    µ¿ÀǾî=antisy
  • antilymphocyte globulin
    Ç׸²ÇÁ±¸ ±Û·ÎºÒ¸°
    Ç׸²ÇÁ±¸ Ç÷û¿¡¼­ ±Û·ÎºÒ¸° ºÐȹÀ» Á¤Á¦ÇÑ °Í.
  • antilyssic
    Ç×±¤°ßº´ÀÇ, Ç×±¤°ßº´ ¾à
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
antibodies, fungal Immunoglobulins induced by substances elaborated by fungi that have an antigenic activity.
(12 Dec 1998)
antibodies, helminth Antibodies produced by human or animal cells following clinical or experimental exposure to parasitic helminth antigens. The IgE class of immunoglobulins is usually formed and released, but IgG, IgM, and IgA may also occur.
(12 Dec 1998)
antibodies, heterophile Antibodies elicited in a different species from which the antigen originated. These antibodies are directed against a wide variety of interspecies-specific antigens, the best known of which are forssman, hanganutziu-deicher (h-d), and paul-bunnell (p-b). Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of infection and latent infectious states as well as in cancer classification.
(12 Dec 1998)
antibodies, monoclonal Antibodies produced by clones of cells such as those isolated after hybridization of activated b lymphocytes with neoplastic cells. These hybrids are often referred to as hybridomas.
(12 Dec 1998)
antibodies, neoplasm Immunoglobulins induced by antigens specific for tumours other than the normally occurring histocompatibility antigens.
(12 Dec 1998)
antibodies, protozoan Antibodies produced by human or animal cells following clinical or experimental exposure to parasitic protozoan antigens.
(12 Dec 1998)
antibodies, viral Immunoglobulins produced as a response to viral antigens; includes all classes of immunoglobulins elicited by all viral components.
(12 Dec 1998)
antibody An immunoglobulin molecule that has a specific amino acid sequence by virtue of which it interacts only with the antigen that induced its synthesis in cells of the lymphoid series (especially plasma cells) or with antigen closely related to it. Antibodies are classified according to their ode of action as agglutinins, bacteriolysins, haemolysins, opsonins, precipitins, etc.
(18 Nov 1997)
antibody affinity A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes.
(12 Dec 1998)
antibody aldolase <enzyme> Prepared by reactive immuninization to catalyze a wide variety of aldol reactions and decarboxylations
Registry number: EC 4.1.2.-
Synonym: fab 33f12, aldolase catalytic antibody
(26 Jun 1999)
antibody combining site <immunology> In immune network theory, an idiotope, an antigenic site of an antibody that is responsible for that antibody binding to an antigenic determinant (epitope).
Also used of the site on a ligand molecule to which a cell surface receptor binds.
(18 Nov 1997)
antibody deficiency disease <syndrome> Any of a group of disorders associated with a defective antibody production due to defects in the B-type lymphocyte system or in T-type lymphocytes; chief manifestation is an increased susceptibility to infection by various microorganisms.
See: agammaglobulinaemia, hypogammaglobulinaemia, immunodeficiency.
Synonym: antibody deficiency disease.
(05 Mar 2000)
antibody deficiency syndrome <syndrome> Any of a group of disorders associated with a defective antibody production due to defects in the B-type lymphocyte system or in T-type lymphocytes; chief manifestation is an increased susceptibility to infection by various microorganisms.
See: agammaglobulinaemia, hypogammaglobulinaemia, immunodeficiency.
Synonym: antibody deficiency disease.
(05 Mar 2000)
Antibody Directed Enzyme Prodrug Therapy <pharmacology> A method for targeting a drug to a specific tissue, in which the targeting agent and the drug are administered separately.
The drug is designed to be inactive (a prodrug) until it is converted by an enzyme, which is the targeting agent. The enzyme is coupled to an antibody that directs it to the tissue of interest. When the enzyme arrives at the tissue, the prodrug is activated only at that site, sparing other tissues from potentially toxic side effects.
Acronym: ADEPT
(14 Nov 1997)
antibody diversity The phenomenon of immense variability characteristic of antibodies, which enables the immune system to react specifically against the essentially unlimited kinds of antigens it encounters. Antibody diversity is accounted for by three main theories: 1) the germ line theory, which holds that each antibody-producing cell has genes coding for all possible antibody specificities, but expresses only the one stimulated by antigen; 2) the somatic mutation theory, which holds that antibody-producing cells contain only a few genes, which produce antibody diversity by mutation; and 3) the gene rearrangement theory, which holds that antibody diversity is generated by the rearrangement of variable region gene segments during the differentiation of the antibody-producing cells.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 9
  • Antibodies, Viral - »õâ Immunoglobulins produced as a response to VIRAL ANTIGENS; includes all classes of immunoglobulins elicited by all viral components.
    Synonyms :
  • Antibody Affinity - »õâ A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes.
    Synonyms : Affinities, Antibody, Antibody Affinities, Antibody Avidities, Avidities, Antibody
  • Antibody Diversity - »õâ The phenomenon of immense variability characteristic of ANTIBODIES. It enables the IMMUNE SYSTEM to react specifically against the essentially unlimited kinds of ANTIGENS it encounters. Antibody diversity is accounted for by three main theories: (1) the Germ Line Theory, which holds that each antibody-producing cell has genes coding for all possible antibody specificities, but expresses only the one stimulated by antigen; (2) the Somatic Mutation Theory, which holds that antibody-producing cells contain only a few genes, which produce antibody diversity by mutation; and (3) the Gene Rearrangement Theory, which holds that antibody diversity is generated by the rearrangement of IMMUNOGLOBULIN VARIABLE REGION gene segments during the differentiation of the ANTIBODY-PRODUCING CELLS.
    Synonyms : Antibody Diversities, Diversities, Antibody, Diversity, Antibody, Germ Line Theories, Theories, Germ Line, Theory, Germ Line
  • Antibody Formation - »õâ The proliferation and differentiation of B-LYMPHOCYTES into PLASMA CELLS or memory cells. On stimulation by ANTIGENS, those cells then produce ANTIBODIES.
    Synonyms : Antibody Responses, Formation, Antibody, Humoral Immunities, Humoral Immunity, Immunities, Humoral, Production, Antibody, Response, Antibody, Responses, Antibody
  • Antibody Specificity - »õâ The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.
    Synonyms : Antibody Specificities, Specificities, Antibody, Specificity, Antibody
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
antidromic conducting nerve impulses in a direction opposite to normal
Ãâó: wordnet.princeton.edu/perl/webwn
anti-G suit worn by fliers and astronauts to counteract the forces of gravity and acceleration
Ãâó: wordnet.princeton.edu/perl/webwn
anticatalyst (chemistry) a substance that retards a chemical reaction or diminishes the activity of a catalyst
Ãâó: wordnet.princeton.edu/perl/webwn
anticoagulation the administration of an anticoagulant drug to retard coagulation of the blood
Ãâó: wordnet.princeton.edu/perl/webwn
antiemetic a drug that prevents or alleviates nausea and vomiting
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • antimasque
    ÀÍ»ì Ã̱Ø
  • antimasque
    ¸·°£ÀÇ ±¤´ë ³îÀÌ
  • antimatter
    ¹Ý¹°Áú
  • antimicrobial
    Ç×±Õ¼ºÀÇ;Ç×±ÕÁ¦(¹°Áú)
  • antimilitarism
    ¹Ý±º±¹ÁÖÀÇ
  • antimissile
    ¹Ì»çÀϹæ¾î¿ëÀÇ
  • antimitotic
    ¼¼Æ÷ ºÐ¿­ ÀúÁö¼ºÀÇ(¹°Áú)
  • antimonarchical
    ±ºÁÖ Á¤Ä¡¸¦ ¹Ý´ëÇÏ´Â
  • antimonarchist
    ±ºÁÖ Á¤Ä¡ ¹Ý´ëÀÚ
  • antimonial
    ¾ÈƼ¸óÀÇ;¾ÈƼ¸óÁúÀÇ
  • antimonic
    ¾ÈƼ¸ó¼ºÀÇ
  • antimonopoly
    µ¶Á¡¿¡ ¹Ý´ëÇÏ´Â;µ¶Á¡ ±ÝÁöÀÇ
  • antimonsoon
    ¹Ý´ë °èÀýdz
  • antimony
    ¾ÈƼ¸ó
  • antimony
    ¾ÈƼ¸ó;¾ÈƼ¸ð´Ï
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 9
anti a drug that limits the formation of urine
anti hormone secreted by the posterior pituitary gland (trade name Pitressin) and also by nerve endings in the hypothalamus
anti an artificial language related to Ido
anti springboks
anti South African gazelle noted for springing lightly into the air
anti South African gazelle noted for springing lightly into the air
anti counteracting the effects of a poison
anti a remedy that stops or controls the effects of a poison
anti (physiology) conducting nerve impulses in a direction opposite to normal
anti an elementary particle with positive charge
anti a drug that prevents or alleviates nausea and vomiting
anti a drug that prevents or alleviates nausea and vomiting
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 9
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á